Literature DB >> 30924130

The role of plasma exchange in the management of autoimmune disorders.

Elisabetta Zanatta1, Martina Cozzi2, Piero Marson3, Franco Cozzi1.   

Abstract

Therapeutic plasma exchange (TPE) has been mainly used in the treatment of autoimmune diseases. The main mechanisms of action of TPE include the removal of circulating autoantibodies, immune complexes, complement components, cytokines and adhesion molecules, along with sensitization of antibody-producing cells to immunosuppressant agents. TPE is useful in autoimmune haematological, renal, rheumatic and neurological diseases, and is recommended for acute disorders, together with relapsed or worsened chronic diseases that are often unresponsive to conventional treatments. The American Society for Apheresis and the British Society of Haematology have published guidelines on the clinical use of apheresis procedures, indicating the different levels of efficacy of TPE. Based on the evidence from current literature and our personal experience, this review discusses the indications and the suggested regimens for TPE in autoimmune haematological and non-haematological disorders.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  autoimmunity; haematological disorders; neurological disorders; plasma exchange; renal/rheumatic diseases

Mesh:

Substances:

Year:  2019        PMID: 30924130     DOI: 10.1111/bjh.15903

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Recent research on immunotherapy for anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Yu-Hang Li; Li Jiang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

Review 2.  Therapeutic plasma exchange in children with acute liver failure (ALF): is it time for incorporation into the ALF armamentarium?

Authors:  Emma C Alexander; Akash Deep
Journal:  Pediatr Nephrol       Date:  2021-10-14       Impact factor: 3.651

3.  Evaluation of membrane-based therapeutic plasma exchange as adjunctive treatment for immune-mediated hematologic disorders in dogs.

Authors:  Thierry Francey; Mathieu Etter; Ariane Schweighauser
Journal:  J Vet Intern Med       Date:  2021-02-11       Impact factor: 3.333

4.  Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy-case report.

Authors:  Sanziana R I Schiopu; Lukas Käsmann; Ulf Schönermarck; Michael Fischereder; Ulrich Grabmaier; Farkhad Manapov; Josefine Rauch; Martin Orban
Journal:  Transl Lung Cancer Res       Date:  2021-02

5.  Clinical efficacy of plasma exchange in patients with autoimmune encephalitis.

Authors:  Yan Zhang; Hui-Jin Huang; Wei-Bi Chen; Gang Liu; Fang Liu; Ying-Ying Su
Journal:  Ann Clin Transl Neurol       Date:  2021-02-20       Impact factor: 4.511

Review 6.  Therapeutic Plasma Exchange: For Cancer Patients.

Authors:  Yuru Hu; Hanshan Yang; Shaozhi Fu; Jingbo Wu
Journal:  Cancer Manag Res       Date:  2022-02-02       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.